TH9138A - Nucleosides for therapeutic use - Google Patents
Nucleosides for therapeutic useInfo
- Publication number
- TH9138A TH9138A TH9001001479A TH9001001479A TH9138A TH 9138 A TH9138 A TH 9138A TH 9001001479 A TH9001001479 A TH 9001001479A TH 9001001479 A TH9001001479 A TH 9001001479A TH 9138 A TH9138 A TH 9138A
- Authority
- TH
- Thailand
- Prior art keywords
- replaced
- halogen
- choose
- nucleosides
- infection
- Prior art date
Links
- 239000002777 nucleoside Substances 0.000 title 1
- 125000003835 nucleoside group Chemical group 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000005110 aryl thio group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000005366 cycloalkylthio group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- -1 cyclopropyl methyl amino Chemical group 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
Abstract
6-ซับสทิทิวเทด-2,3-ไดดีออกซินิวคลิโอโซด์สำหรับใช้ในการรักษาหรือป้องกันการติดโรคตับอักเสบชนิด B (HBV) และสาร ประกอบใหม่ที่เฉพาะเจาะจง 6-(ไซโคลโพรพิลเมธิลอะมิโน) พวิ รีน-9-B-D-2,3-ไดดีออกวิไรโบฟิวแรโนไซด์สำหรับใช้ในการ รักษาหรือป้องกัน HBV ในมนุษย์หรือเรโทรไวรัส เช่น การติด เชื้อไวรัสทำให้ภูมิคุ้มกันบกพร่องในมนุษย์ (HIV) และสูตร ผสมทางเภสัชศาสตร์ที่มีสารประกอบหลังนี้ สิทธิบัตรยา 6-Substitutade-2,3-Dioxynucleoside for the treatment or prevention of hepatitis B (HBV) infection and specific novel compounds. 6- (cyclopropyl methyl amino) pvirine-9-B-D-2,3-dydugiribofuranoside for use in Treat or prevent HBV in humans or retroviruses, such as human immunodeficiency virus (HIV) infection and a pharmaceutical formula containing the latter compound.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH9138A true TH9138A (en) | 1991-07-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK602988D0 (en) | NUCLEOSIDE DERIVATIVES WITH ANTIVIRAL EFFECT AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS | |
| FI894545L (en) | THERAPEUTIC NUCLEOSIDES. | |
| NO20023852L (en) | Nucleoside analogs with carboxamidine-modified bicyclic base | |
| PH31397A (en) | Use of 1,3-oxathiolane nucleoside analogues in thetreatment of hepatitis b. | |
| NZ609146A (en) | Modified 4’-nucleosides as antiviral agents | |
| DK104994A (en) | Use of Beta-Anomeric Compounds for the Preparation of Pharmaceuticals for the Treatment or Prevention of HIV or Hepatitis B Virus | |
| DK0430045T3 (en) | Ascorbic acid ethocopheryl phosphate diesters to inhibit Maillard's reaction | |
| NZ610715A (en) | Antiviral compounds and methods | |
| PH25859A (en) | Composition for treatment of ischemic disorder | |
| EP0275888A3 (en) | Tricyclic benzimidazoles, process for their preparation and use as medicaments | |
| DE68901153D1 (en) | DERIVATIVES OF PURIN, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION. | |
| ES2132284T3 (en) | CARBAMATE DERIVATIVES OF 2- (PIPERIDIN-4-IL, PIRIDIN-4-IL AND TETRAHIDROPIRIDIN-4-IL) -BENZOFURANE-7, THEIR PREPARATION AND USE AS ACETHYLCHOLINESTERASE INHIBITORS. | |
| DE69030616D1 (en) | Pharmaceutical compositions for inhibiting the Maillard reaction | |
| TH9138A (en) | Nucleosides for therapeutic use | |
| ATE124050T1 (en) | CHIRAL 2-(PHOSPHONOMETHOXY)PROPYL-GUANINE AS ANTIVIRAL AGENTS. | |
| YU119491A (en) | NEW ANTI-VIRUS TETRAHYDROIMIDASO [1,4] BENZODIAZEPIN-2- (TI) ONE AND THE PROCESS FOR THEIR OBTAINING | |
| DE59107970D1 (en) | 3- (Mercaptoalkyl) -quinazoline-2,4 (1H, 3H) -diones, process for their preparation and pharmaceutical preparations | |
| TH5989A (en) | Nucleosides used to treat disease | |
| ATE116296T1 (en) | ACID ADDITION SALTS OF AN OPTICALLY ACTIVE ALANINE ANILIDE COMPOUND AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME. | |
| ZA929974B (en) | Pharmaceutical composition for inhibiting the infection with AIDS virus | |
| TH9666A (en) | Nucleosides used in the treatment of disease | |
| TH14424A (en) | Heterocyclic compounds | |
| TH16620A (en) | "A useful HIV protease inhibitor for the treatment of AIDS" | |
| ES2078139B1 (en) | ANTIRRETROVIRAL COMPOSITIONS CONTAINING IODINE COMPOUNDS. |